A food-based, low-energy, low-carbohydrate diet for people with type 2 diabetes in primary care: A randomized controlled feasibility trial.


Journal

Diabetes, obesity & metabolism
ISSN: 1463-1326
Titre abrégé: Diabetes Obes Metab
Pays: England
ID NLM: 100883645

Informations de publication

Date de publication:
04 2020
Historique:
received: 25 10 2019
revised: 05 11 2019
accepted: 07 11 2019
pubmed: 12 11 2019
medline: 25 6 2021
entrez: 12 11 2019
Statut: ppublish

Résumé

To examine the feasibility of a food-based, low-energy, low-carbohydrate diet with behavioural support delivered by practice nurses for patients with type 2 diabetes. People with type 2 diabetes and a body mass index (BMI) of ≥30 kg/m Forty-eight people were screened, 33 enrolled and 32 followed-up. Mean (±SD) weight loss in the intervention group was 9.5 kg (± 5.4 kg) compared with 2 kg (± 2.5 kg) in the control group (adjusted difference - 7.5 kg [-11.0 to -4.0, P < 0.001]). Mean reduction in HbA1c in the intervention group was 16.3 mmol/mol (± 13.3 mmol/mol) compared with 0.7 mmol/mol (±4.5 mmol/mol) in the control group (difference - 15.7 mmol/mol [-24.1 to -7.3, P < 0.001]). It is feasible to recruit participants to a food-based, low-energy, low-carbohydrate intervention, for practice nurses to deliver the programme in primary care, and to retain participants in both groups. There is evidence of clinically significant short-term improvements in weight and glycaemic control.

Identifiants

pubmed: 31709697
doi: 10.1111/dom.13915
pmc: PMC7079070
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

512-520

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIHR Oxford Applied Research Centre
Pays : International

Informations de copyright

© 2019 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.

Références

Diabetes Care. 1995 Jun;18(6):754-60
pubmed: 7555499
BMJ. 2017 May 23;357:j2099
pubmed: 28536104
Diabetes Care. 2011 Sep;34(9):1919-25
pubmed: 21775759
Lancet. 2018 Feb 10;391(10120):541-551
pubmed: 29221645
BMJ. 2011 Nov 03;343:d6500
pubmed: 22053315
Diabetologia. 2004 Aug;47(8):1380-4
pubmed: 15309288
Lancet Diabetes Endocrinol. 2019 May;7(5):326-327
pubmed: 30852131
Br J Gen Pract. 2019 Jul;69(684):360-361
pubmed: 31249097
Diabetes Care. 2014 Apr;37(4):922-33
pubmed: 24652723
BMJ. 2018 Sep 26;362:k3760
pubmed: 30257983
Diabetes Obes Metab. 2020 Apr;22(4):512-520
pubmed: 31709697
Diabetes Res Clin Pract. 2018 May;139:239-252
pubmed: 29522789
Lancet. 2019 Feb 2;393(10170):434-445
pubmed: 30638909
BMJ. 2018 Jun 13;361:k2234
pubmed: 29898883
BMJ Open. 2019 Jan 17;9(1):e026460
pubmed: 30659044
BMJ. 2008 Mar 1;336(7642):491-5
pubmed: 18276664
Diabetes Care. 1998 Dec;21(12):2191-2
pubmed: 9839117

Auteurs

Elizabeth Morris (E)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
NIHR Biomedical Research Centre, Oxford, UK.

Paul Aveyard (P)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
NIHR Biomedical Research Centre, Oxford, UK.

Pamela Dyson (P)

NIHR Biomedical Research Centre, Oxford, UK.
Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Michaela Noreik (M)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
NIHR Biomedical Research Centre, Oxford, UK.

Clare Bailey (C)

Burnham Health Centre, Slough, UK.

Robin Fox (R)

Bicester Health Centre, Bicester, UK.

Derek Jerome (D)

PPI representative, the DIAMOND study, University of Oxford, Oxford, UK.

Garry D Tan (GD)

NIHR Biomedical Research Centre, Oxford, UK.
Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Susan A Jebb (SA)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
NIHR Biomedical Research Centre, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH